Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06578156 · ClinicalTrials.gov registry record · NA

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

A NA study of COPD, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06578156 is a NA study of COPD that is actively recruiting participants, run by University of Miami. The registered enrollment target is 30 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06578156, a NA study of COPD, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.

Conditions Studied

Interventions

  • DEVICE Nasal High Flow Cannula
  • DEVICE Nasal Low Flow Cannula

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-12-12
Est. Completion 2027-12-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06578156

The ClinicalTrials.gov registry entry for NCT06578156 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Nasal High Flow Cannula is the first listed.

NCT06578156 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06578156 about?

NCT06578156 is a clinical study titled "Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD". This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with ...

What is the current status of trial NCT06578156?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-12-12. Estimated completion is 2027-12-31.

What conditions does trial NCT06578156 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT06578156?

The interventions under investigation include: Nasal High Flow Cannula (DEVICE), Nasal Low Flow Cannula (DEVICE).

Who is sponsoring clinical trial NCT06578156?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06578156 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.